Physician profile
Mitchell F Barney
NPI 1912986142
$5,795.78
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $54.64 · 2021: $1,152 · 2022: $153 · 2023: $3,117 · 2024: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $267.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,285.73 | 2021-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Abbvie INC. | $192.63 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $92.75 | 2019-2022 | |
| Allergan, INC. | $50.48 | 2019 | |
| Boston Scientific Corporation | $40.40 | 2021-2022 | |
| Organon LLC | $28.59 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.23 | 2019-2020 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Scynexis, INC. | $15.58 | 2022 | |
| Lupin INC. | $12.23 | 2019 | |
| Roche Diagnostics Corporation | $12.03 | 2019 | |
| Exeltis, USA INC. | $11.85 | 2022 | |
| Coopersurgical, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Barney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.